30
Participants
Start Date
August 14, 2012
Primary Completion Date
April 24, 2014
Study Completion Date
April 24, 2014
SSP-004184AQ
"Long term extension study of 8-75 mg/kg/d of SSP-004184AQ (equivalent to 7-68 mg/kg/d free acid or active form)"
San Luigi Hospital Thalassemia Centre, Orbassano
Siriraj Hospital, Mahidol University, Bangkok
Ospedale Galliera, Genova
Children's Hospital Oakland, Oakland
Children's Hospital of Boston, Boston
The Hospital for Sick Children, Toronto
Toronto General Hospital, Toronto
Ospedale Regionale Microcitemie, Cagliari
Whittington Hospital, London
Lead Sponsor
Shire
INDUSTRY